当前位置: X-MOL 学术Aging Ment. Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The role of age and opioid agonist treatment on substance use treatment completion in the United States
Aging & Mental Health ( IF 3.4 ) Pub Date : 2021-05-17 , DOI: 10.1080/13607863.2021.1925223
Carissa van den Berk Clark 1 , Joseph G Pickard 2 , Theresa Drallmeier 1
Affiliation  

Abstract

Background

There is a large body of research indicating that substance use disorder treatment completion leads to higher rates of sustained recovery. However, not much is known about how age and opioid treatment programs (OTPs) OTPinteract to affect treatment completion. The purpose of this article is to better understand the pathway between age, OTP, and treatment completion.

Methods

Data from the US 2017 Treatment Episodes Data Set was analyzed. Seemingly unrelated bivariate probit regression was used to determine whether OTP access mediates the relationship between age and treatment completion. We used propensity score matching to simulate the effects of a randomized control trial and to attenuate the likelihood of a Type 1 error.

Results

Older adults have a higher likelihood than their younger counterparts of completing treatment regardless of OTP status in inpatient and outpatient settings. Those who received OTP in inpatient treatment had a 45% increased probability of completing treatment in detox settings and a 41% increased probability of completing treatment in inpatient settings. Older adults (age 50+) were more likely to receive OTP than their younger counterparts. There is a small but significant indirect effect of age on treatment completion in inpatient settings.

Conclusions

Older adults are more likely to receive OTP in both inpatient and outpatient settings. However, age does not appear to affect the probability of treatment completion when individuals receive OTP, except in inpatient settings. Implications are discussed.



中文翻译:

年龄和阿片受体激动剂治疗对美国物质使用治疗完成的作用

摘要

背景

大量研究表明,完成物质使用障碍治疗会导致更高的持续康复率。然而,对于年龄和阿片类药物治疗计划 (OTP) OTP 如何相互作用以影响治疗完成,我们知之甚少。本文的目的是更好地了解年龄、OTP 和治疗完成之间的路径。

方法

分析了来自美国 2017 年治疗发作数据集的数据。看似不相关的双变量概率回归用于确定 OTP 访问是否介导了年龄和治疗完成之间的关系。我们使用倾向得分匹配来模拟随机对照试验的效果并降低 1 型错误的可能性。

结果

无论住院和门诊环境中的 OTP 状态如何,老年人完成治疗的可能性都高于年轻人。在住院治疗中接受 OTP 的患者在排毒环境中完成治疗的概率增加了 45%,在住院环境中完成治疗的概率增加了 41%。与年轻同龄人相比,老年人(50 岁以上)更有可能接受 OTP。在住院环境中,年龄对治疗完成的间接影响很小但很显着。

结论

老年人在住院和门诊都更有可能接受 OTP。然而,当个体接受 OTP 时,年龄似乎不会影响治疗完成的可能性,除非在住院环境中。讨论了影响。

更新日期:2021-05-17
down
wechat
bug